KTTA
Pasithea Therapeutics Corp.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
—
Pasithea Therapeutics Corp.
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
—
No changes.
No changes.
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Pasithea Therapeutics Corp..
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Pasithea Therapeutics Corp..
Annual filing, covered
10-K parsed · Mar 30 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 30 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Pasithea Therapeutics Corp.
0.53
pre 0.52 −1.89%
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
+17.33%
shares held · 10 largest managers
| Manager | Value | % base | |
|---|---|---|---|
| Cable Car Capital | $1.5M | 17.85% | +148.68% |
| Stonepine | $1.1M | 13.10% | +164.82% |
| Jupiter Topco | $1.1M | 12.61% | — |
| Adage Capital Partners GP | $1.1M | 12.50% | 0.00% |
| Opaleye | $1.1M | 12.20% | new |
| Manager | Value | % base | |
|---|---|---|---|
| Cable Car Capital | $1.5M | 17.85% | +148.68% |
| Stonepine | $1.1M | 13.10% | +164.82% |
| Jupiter Topco | $1.1M | 12.61% | — |
| Adage Capital Partners GP | $1.1M | 12.50% | 0.00% |
| Opaleye | $1.1M | 12.20% | new |
Expected move
No implied move.